Clinical trial No longer in our active list Observational Ages 18 and up

New scoring system for ICU patients considering inflammation and nutrition

Official title: Comparison of the New Score (APACHE-INf), Including Inflammatory and Nutritional Parameters, With APACHE-II in the Prognosis of Patients Admitted to ICU

Run by Bursa City Hospital · NCT05955547 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new scoring system for ICU patients that takes into account inflammation and nutrition to see if it can better predict their outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment15000 (estimated)
SponsorBursa City Hospital
Government
Locations1 site (Nilüfer, Bursa)
Trial IDNCT05955547 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who are admitted to the ICU.

Probably not a fit

Patients under 18 years old or those with incomplete data will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a new prognostic scoring system, APACHE-INf, for patients admitted to intensive care units (ICUs) by incorporating inflammatory parameters and nutritional status into the assessment. Current scoring systems, like APACHE-II, primarily focus on organ dysfunction and overlook these critical factors that significantly impact patient outcomes. By evaluating the role of inflammation and nutritional deficiencies, the study seeks to enhance the accuracy of prognosis predictions for ICU patients. The research will involve collecting data from patients over 18 years old admitted to the ICU at Bursa City Hospital and its affiliated institutions.

Why it matters

Potential benefit: If successful, this new scoring system could lead to improved patient outcomes by enabling more accurate prognostic assessments and timely interventions.

How similar studies have gone: While existing studies have focused on inflammation and nutrition separately, this approach of integrating both into a prognostic scoring system is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ICU admission
* Age over 18

Exclusion Criteria:

* Incomplete data
* Age under 18

Where it's running

  • University of Health Sciences, Bursa Sehir Training & Research Hospital
    Nilüfer, Bursa, Turkey
    Recruiting

Study contacts

  • Principal investigator: Nizameddin Koca, MD — University of Health Sciences, Bursa Sehir Training & Research Hospital
  • Study coordinator: Nizameddin Koca, MD
  • Email: nkoca@yahoo.com
  • Phone: 05052324063

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.